Hikma Pharmaceuticals Statistics
Total Valuation
LON:HIK has a market cap or net worth of GBP 3.49 billion. The enterprise value is 4.76 billion.
Important Dates
The next estimated earnings date is Monday, February 22, 2027.
| Earnings Date | Feb 22, 2027 |
| Ex-Dividend Date | Aug 13, 2026 |
Share Statistics
LON:HIK has 207.23 million shares outstanding. The number of shares has decreased by -0.92% in one year.
| Current Share Class | 207.23M |
| Shares Outstanding | 207.23M |
| Shares Change (YoY) | -0.92% |
| Shares Change (QoQ) | -1.93% |
| Owned by Insiders (%) | 2.84% |
| Owned by Institutions (%) | 58.56% |
| Float | 139.22M |
Valuation Ratios
The trailing PE ratio is 12.73 and the forward PE ratio is 9.27. LON:HIK's PEG ratio is 1.40.
| PE Ratio | 12.73 |
| Forward PE | 9.27 |
| PS Ratio | 1.36 |
| PB Ratio | 1.84 |
| P/TBV Ratio | 3.33 |
| P/FCF Ratio | 19.48 |
| P/OCF Ratio | 9.48 |
| PEG Ratio | 1.40 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 7.10, with an EV/FCF ratio of 26.55.
| EV / Earnings | 16.33 |
| EV / Sales | 1.85 |
| EV / EBITDA | 7.10 |
| EV / EBIT | 9.29 |
| EV / FCF | 26.55 |
Financial Position
The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.77.
| Current Ratio | 1.98 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | 2.20 |
| Debt / FCF | 8.22 |
| Interest Coverage | 7.01 |
Financial Efficiency
Return on equity (ROE) is 15.41% and return on invested capital (ROIC) is 12.91%.
| Return on Equity (ROE) | 15.41% |
| Return on Assets (ROA) | 6.80% |
| Return on Invested Capital (ROIC) | 12.91% |
| Return on Capital Employed (ROCE) | 15.30% |
| Weighted Average Cost of Capital (WACC) | 6.53% |
| Revenue Per Employee | 271,253 |
| Profits Per Employee | 30,703 |
| Employee Count | 9,500 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 1.69 |
Taxes
In the past 12 months, LON:HIK has paid 89.69 million in taxes.
| Income Tax | 89.69M |
| Effective Tax Rate | 23.29% |
Stock Price Statistics
The stock price has increased by +6.91% in the last 52 weeks. The beta is 0.62, so LON:HIK's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +6.91% |
| 50-Day Moving Average | 1,643.46 |
| 200-Day Moving Average | 1,514.14 |
| Relative Strength Index (RSI) | 54.08 |
| Average Volume (20 Days) | 551,372 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:HIK had revenue of GBP 2.58 billion and earned 291.68 million in profits. Earnings per share was 1.32.
| Revenue | 2.58B |
| Gross Profit | 1.14B |
| Operating Income | 512.52M |
| Pretax Income | 385.14M |
| Net Income | 291.68M |
| EBITDA | 662.50M |
| EBIT | 512.52M |
| Earnings Per Share (EPS) | 1.32 |
Full Income Statement Balance Sheet
The company has 217.82 million in cash and 1.47 billion in debt, with a net cash position of -1.26 billion or -6.07 per share.
| Cash & Cash Equivalents | 217.82M |
| Total Debt | 1.47B |
| Net Cash | -1.26B |
| Net Cash Per Share | -6.07 |
| Equity (Book Value) | 1.91B |
| Book Value Per Share | 8.78 |
| Working Capital | 1.02B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 368.56 million and capital expenditures -189.18 million, giving a free cash flow of 179.38 million.
| Operating Cash Flow | 368.56M |
| Capital Expenditures | -189.18M |
| Depreciation & Amortization | 152.18M |
| Net Borrowing | 276.06M |
| Free Cash Flow | 179.38M |
| FCF Per Share | 0.87 |
Full Cash Flow Statement Margins
Gross margin is 44.05%, with operating and profit margins of 19.89% and 11.32%.
| Gross Margin | 44.05% |
| Operating Margin | 19.89% |
| Pretax Margin | 14.95% |
| Profit Margin | 11.32% |
| EBITDA Margin | 25.71% |
| EBIT Margin | 19.89% |
| FCF Margin | 6.86% |
Dividends & Yields
This stock pays an annual dividend of 0.62, which amounts to a dividend yield of 3.68%.
| Dividend Per Share | 0.62 |
| Dividend Yield | 3.68% |
| Dividend Growth (YoY) | 0.96% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 47.55% |
| FCF Payout Ratio | 74.09% |
| Buyback Yield | 0.92% |
| Shareholder Yield | 4.60% |
| Earnings Yield | 7.86% |
| FCF Yield | 5.13% |
Dividend Details Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Analyst Forecast
The average price target for LON:HIK is 2,025.68, which is 20.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 2,025.68 |
| Price Target Difference | 20.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 3.58% |
| EPS Growth Forecast (3Y) | 5.24% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:HIK has an Altman Z-Score of 2.7 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.7 |
| Piotroski F-Score | 6 |